The fight against coronary heart disease (Covid-19) has entered a key phase as countries have begun vaccine initiatives to immunize people against the pandemic. While the United Kingdom became the first country to start vaccinating Covid-19 outside the test stage last Tuesday, the United States also began its vaccination on Monday. Both countries have granted emergency authorization of use (EUA) to the vaccine candidate of Pfizer Inc; Canada and Bahrain are also among countries that have given vaccine candidate Pfizer permission to use in emergencies.
Click here for a full covid of Covid-19
Here are the latest updates on the Covid-19 vaccine development front:
1. President Donald Trump on Monday announced administration of the first Covid-19 vaccine in the United States. “First vaccine administered. Congratulations United States! Congratulations World! Tweeted Trump as vaccinations began across the United States. While health workers are first in line for shooting, interim defense secretary, Christopher Miller, was among those who received a shot of the Pfizer-BioNTech SE vaccine.
Also Read | The first Covid-19 vaccine administered in the United States, tweeted President Donald Trump
2. Developers of Russian Sputnik V, which Moscow claims are the world’s first registered vaccine against Covid-19, said on Monday that it showed an effectiveness of 91.4% based on the final analysis of clinical trial data. The calculation, the developers said, was based on analysis of data from volunteers who received the first and second doses of Sputnik V, or placebo, at “the third and final checkpoint of 78 confirmed cases according to the clinical Phase III trial protocol. “
Also Read | Sputnik V more than 91% effect in final analysis, data show
3. Israel’s defense ministry said the Israeli Institute for Biological Research (IIBR) has “successfully completed” phase one of the domestic tests on Covid-19 vaccine and plans to begin a second phase “in the coming days.” The second phase, the ministry said, will take place with about 1,000 volunteers, which, if successful, would be followed by a third phase with up to 30,000 volunteers.